Safety study of Fluorothiazinone infusion in healthy volunteers
This study tests a new drug called Fluorothiazinone given through an IV drip. It looks at how safe the drug is and how the body processes it. Healthy volunteers aged 18-45 can join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You must be in good health with no major medical conditions.
- You must have negative tests for HIV, hepatitis B, hepatitis C, and syphilis.
- You must not use illegal drugs or drink too much alcohol.
- Women must not be pregnant and must use effective birth control during the study.
- You must not have taken part in another clinical trial in the last 90 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
This early-phase study tests a new oral tablet (YR011) in healthy volunteers to see how safe it is and how the body processes it. It helps find the right dose for future studies.
Hear when a new Safety and Pharmacokinetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.